Cerebrospinal fluid neurofilament light and tau protein as mortality biomarkers in parkinsonism

A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

(2018) Lorenzo Gaetani et al.   Alzheimers Research & Therapy

Early predictors of mortality in parkinsonism and Parkinson disease

(2018) David Bäckström et al.   NEUROLOGY

CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP

(2017) Julio C. Rojas et al.   NEUROLOGY

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

(2017) Brit Mollenhauer et al.   NEUROLOGY

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism

(2017) Rodolfo Savica et al.   JAMA Neurology

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy

(2016) Julio C. Rojas et al.   Annals of Clinical and Translational Neurology

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis

(2014) R. Tortelli et al.   EUROPEAN JOURNAL OF NEUROLOGY

Mortality in Parkinson's disease: A systematic review and meta-analysis

(2014) Angus D. Macleod et al.   MOVEMENT DISORDERS

Mortality in Parkinson's disease: A 38-year follow-up study

(2014) Bernadette Pinter et al.   MOVEMENT DISORDERS

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

(2014) T. Skillback et al.   NEUROLOGY

Parkinson's disease and risk of mortality: meta-analysis and systematic review

(2013) J. Xu et al.   ACTA NEUROLOGICA SCANDINAVICA

High Tau Levels in Cerebrospinal Fluid Predict Rapid Decline and Increased Dementia Mortality in Alzheimer's Disease

(2013) M. Degerman Gunnarsson et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

The natural history of multiple system atrophy: a prospective European cohort study

(2013) Gregor K Wenning et al.   LANCET NEUROLOGY

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

(2013) Henrik Zetterberg et al.   Nature Reviews Neurology

Criteria for the diagnosis of corticobasal degeneration

(2013) M. J. Armstrong et al.   NEUROLOGY

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients

(2013) Claudia dell'Aquila et al.   PARKINSONISM & RELATED DISORDERS

α-Synucleinopathy phenotypes

(2013) Heather McCann et al.   PARKINSONISM & RELATED DISORDERS

CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls

(2013) Megan K. Herbert et al.   PARKINSONISM & RELATED DISORDERS

Fluid Biomarkers in Alzheimer Disease

(2013) K. Blennow et al.   Cold Spring Harbor Perspectives in Medicine

Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

(2012) Sara Hall et al.   ARCHIVES OF NEUROLOGY

CSF biomarkers predict a more malignant outcome in Alzheimer disease

(2010) A. K. Wallin et al.   NEUROLOGY

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY